Markers of pulmonary vasculopathy, such as vascular cell adhesion molecule 1 (VCAM-1), monocyte chemoattractant protein 1 (MCP-1), and asymmetric dimethylarginine (ADMA), have been reported as useful biomarkers of ILD in RA patients and can help in the differential diagnosis of RA-ILD from IPF [108]. This evidence concerns the gene CCL2 and rheumatoid arthritis.